An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus

Summary

This is an open-label, expanded access protocol, designed to offer treatment with SAGE-547 to subjects in SRSE, and to evaluate the efficacy and safety of SAGE-547 administered as a continuous intravenous infusion to these subjects

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications